Journal of Medicinal Chemistry · 2024 · 13 citations · 41 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationEnzyme InhibitionLigand BindingMolecular DockingProtein-ligand DockingAging-related PathologyHigh-throughput Virtual ScreeningIsoform DiscoveryIsoform IdentificationTherapeutic Target Identification
Sirtuins are NAD + -dependent protein lysine deacylases implicated in aging-related diseases. Mammalian Sirtuin 4 (Sirt4) is located in mitochondria and a potential therapeutic target for cancer and metabolic diseases, but no potent and selective Sirt4 inhibitors have been reported. Here, we describe the identification of potent Sirt4-specific small-molecule inhibitors. Testing hits from a target-based virtual screen revealed 12 active compounds. A focused screen based on two top compounds, followed by structure-assisted design of derivatives, yielded four first-in-class potent Sirt4 inhibitors. Kinetic analyses indicate compound competition with the acyl peptide substrate, consistent with the docking models and implicating Sirt4’s unique acyl binding site. The compounds indeed show preference for Sirt4 over other isoforms, with one of them ( 69 ) being highly isoform selective, and they are active in cells. Our results provide first lead compounds and mechanistic insights for optimization toward Sirt4-specific inhibitors useful as experimental tools and potential therapeutics.
41
Development and testing of a general amber force field
Junmei Wang, Romain M. Wolf, James W. Caldwell et al. · Journal of Computational Chemistry · 2004 · 19.6K citations
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
Jintang Du, Yeyun Zhou, Xiaoyang Su et al. · Science · 2011 · 1.4K citations · Full text
Lysine Glutarylation Is a Protein Posttranslational Modification Regulated by SIRT5
Minjia Tan, Chao Peng, Kristin A. Anderson et al. · Cell Metabolism · 2014 · 882 citations · Full text